JK Agri Genetics Ltd
JK Agri Genetics Ltd (JKAGL), part of the
JK Group and a 67.56% subsidiary of Bengal
& Assam Company Ltd, research, develops, produces, processes and markets hybrid /certified seeds under the JK Seeds brand.
Its portfolio covers cotton, maize, paddy,
pearl millet/bajra, jowar/sorghum, mustard, wheat, sorghum-Sudan grass and vegetables such as tomato, okra and chilli.[1]
- Market Cap ₹ 121 Cr.
- Current Price ₹ 262
- High / Low ₹ 435 / 234
- Stock P/E
- Book Value ₹ 225
- Dividend Yield 0.00 %
- ROCE 5.25 %
- ROE -8.06 %
- Face Value ₹ 10.0
Pros
- Company is almost debt free.
- Stock is trading at 1.17 times its book value
Cons
- Company has low interest coverage ratio.
- The company has delivered a poor sales growth of -6.77% over past five years.
- Company has a low return on equity of -13.2% over last 3 years.
- Earnings include an other income of Rs.4.98 Cr.
- Company's cost of borrowing seems high
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 205 | 186 | 191 | 202 | 191 | 180 | 224 | 246 | 201 | 148 | 162 | 158 | 145 | |
| Sales growth | +11% | -9% | +2% | +6% | -6% | -6% | +24% | +10% | -18% | -26% | +9% | -3% | -12% |
| 174 | 163 | 165 | 175 | 174 | 184 | 203 | 231 | 209 | 173 | 172 | 155 | 147 | |
| Operating Profit | 31 | 23 | 26 | 27 | 17 | -4 | 21 | 15 | -8 | -25 | -10 | 2 | -2 |
| OPM % | 15% | 12% | 14% | 13% | 9% | -2.3% | 9% | 6% | -4.1% | -17% | -6% | 1.6% | -1.2% |
| 2 | 1 | 1 | 1 | 1 | 0 | -1 | 4 | 3 | 7 | 18 | 6 | 5 | |
| Interest | 10 | 11 | 8 | 8 | 10 | 9 | 6 | 6 | 7 | 8 | 6 | 5 | 4 |
| Depreciation | 5 | 4 | 3 | 3 | 2 | 4 | 4 | 3 | 2 | 3 | 4 | 4 | 3 |
| Profit before tax | 17 | 9 | 16 | 17 | 6 | -16 | 10 | 10 | -15 | -30 | -2 | 0 | -3 |
| Tax % | 29% | 12% | 25% | 28% | 11% | -34% | 28% | 25% | -29% | -30% | 2% | 2,858% | |
| 12 | 8 | 12 | 12 | 5 | -11 | 7 | 8 | -11 | -21 | -2 | -7 | -11 | |
| EPS in Rs | 33.91 | 22.25 | 33.82 | 33.27 | 13.82 | -25.90 | 15.46 | 16.67 | -23.29 | -44.90 | -5.39 | -15.46 | -22.67 |
| Dividend Payout % | 9% | 13% | 12% | 12% | 11% | 0% | 10% | 9% | 0% | 0% | 0% | 0% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | -2% |
| 5 Years: | -7% |
| 3 Years: | -8% |
| TTM: | -12% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 7% |
| TTM: | -440% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | -5% |
| 5 Years: | -16% |
| 3 Years: | -14% |
| 1 Year: | -36% |
| Return on Equity | |
|---|---|
| 10 Years: | -2% |
| 5 Years: | -8% |
| 3 Years: | -13% |
| Last Year: | -8% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | Sep 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 4 | 4 | 4 | 4 | 4 | 4 | 5 | 5 | 5 | 5 | 5 | 5 | 5 |
| Reserves | 54 | 61 | 73 | 83 | 86 | 107 | 131 | 137 | 126 | 105 | 103 | 96 | 100 |
| 58 | 58 | 36 | 46 | 55 | 37 | 26 | 32 | 40 | 32 | 3 | 0 | 4 | |
| 120 | 123 | 162 | 169 | 119 | 110 | 147 | 171 | 160 | 163 | 187 | 172 | 148 | |
| Total Liabilities | 236 | 246 | 273 | 302 | 264 | 258 | 308 | 345 | 331 | 305 | 297 | 272 | 256 |
| 30 | 27 | 38 | 36 | 34 | 36 | 33 | 31 | 29 | 32 | 19 | 22 | 28 | |
| CWIP | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 10 | 17 | 18 | 7 | 0 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 23 | 19 | 51 | 57 | 98 | 73 | 71 |
| 205 | 219 | 236 | 266 | 230 | 223 | 252 | 295 | 241 | 200 | 162 | 170 | 157 | |
| Total Assets | 236 | 246 | 273 | 302 | 264 | 258 | 308 | 345 | 331 | 305 | 297 | 272 | 256 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -5 | 13 | 34 | -0 | 2 | 25 | 21 | -1 | 13 | 37 | 3 | -28 | |
| -1 | 1 | -2 | -1 | -0 | 0 | -22 | 5 | -40 | -15 | 32 | 30 | |
| -5 | -12 | -31 | 1 | -2 | 1 | -4 | -1 | 1 | -22 | -34 | -7 | |
| Net Cash Flow | -10 | 1 | 1 | -1 | 0 | 27 | -5 | 4 | -26 | -1 | 1 | -5 |
| Free Cash Flow | -6 | 12 | 31 | -2 | 2 | 25 | 20 | -2 | 2 | 24 | 72 | -29 |
| CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit | -3% | 67% | 144% | 12% | 24% | -622% | 103% | 12% | -163% | -145% | -42% | -1,122% |
Ratios
Standalone / View Consolidated
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 151 | 160 | 174 | 195 | 140 | 131 | 125 | 154 | 127 | 129 | 96 | 88 |
| Inventory Days | 393 | 432 | 537 | 592 | 612 | 379 | 434 | 437 | 489 | 455 | 301 | 469 |
| Days Payable | 236 | 267 | 403 | 412 | 330 | 199 | 313 | 351 | 337 | 338 | 387 | 396 |
| Cash Conversion Cycle | 309 | 326 | 308 | 376 | 421 | 312 | 247 | 240 | 278 | 246 | 9 | 161 |
| Working Capital Days | 64 | 97 | 63 | 72 | 109 | 86 | 73 | 91 | 51 | -44 | -139 | -53 |
| ROCE % | 26% | 17% | 21% | 20% | 11% | -5% | 13% | 9% | -5% | -14% | -7% | 5% |
Insights
In beta| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expenditure INR crore |
|
|||||||||||
| Multi-location Trial Centers count |
||||||||||||
| Number of Distributors count |
||||||||||||
| Number of Retailers count |
||||||||||||
| Number of States Covered count |
||||||||||||
| Export Sales as % of Total Revenue % |
||||||||||||
| Number of R&D Scientists count |
||||||||||||
Extracted by Screener AI
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
- Newspaper Publication in respect of Special Window opened for Transfer and Dematerialisation of Physical Securities.
-
Disclosure Under Regulation 30 Of SEBI (LODR) Regulations, 2015
- Three GST appeal orders for FY22-FY24 allowed; impugned demand orders annulled, no financial impact.
-
Disclosure Under Regulation 30 Of SEBI (LODR) Regulations, 2015
- Board approved transfer of leasehold rights in 5.28 acres for ₹19.80 crore, subject to approvals.
-
Unaudited Financial Results For The Second Quarter And Half Year Ended 30Th September 2026
- Board approved Q2 FY26 results; net loss Rs 701.06 lakh, H1 profit Rs 385.62 lakh.
-
Board Meeting Outcome for Outcome Of The Board Meeting Held On 30Th October 2026.
- Board approved Q2/H1 FY2026 unaudited results; revenue Rs1,449.74 lakh, H1 profit Rs385.62 lakh.
Annual reports
-
Annual Report 2026
from bse
-
Annual Report 2025
from bse
-
Annual Report 2024
from bse
-
Annual Report 2023
from bse
-
Annual Report 2022
from bse
-
Annual Report 2021
from bse
-
Annual Report 2020
from bse
-
Annual Report 2019
from bse
-
Annual Report 2018
from bse
-
Annual Report 2017
from bse
-
Annual Report 2016
from bse
-
Annual Report 2015
from bse
-
Annual Report 2014
from bse
-
Annual Report 2013
from bse
-
Annual Report 2012
from bse
Business Overview:
JKAGL is a part of JK Group. It is in the research and development, production, processing, and marketing of Field Crops, Cotton, Vegetables, Plant Nutrition, etc. Company sells products under the brand name JK Seeds. The company is shifting processing and packing from an in-house model towards lower-cost tolling/third-party arrangements and has reduced territories, distributors and low-margin or slow-moving crops to improve profitability. [1]